연구동향 분석

여성 우울증 환자에서 Aripiprazole과 Bupropion 부가요법의 우울증상 및안전성에 대한 효과 비교 : 사후분석연구

금무성 천은진 이광헌 구본훈 이영지 박영우 이종훈 이승재 성형모 2018년

논문상세정보
인용/피인용

' 여성 우울증 환자에서 Aripiprazole과 Bupropion 부가요법의 우울증상 및안전성에 대한 효과 비교 : 사후분석연구' 의 참고문헌

  • 한국판 Hamilton 우울증 평가 척도의 신뢰도,타당도 연구
  • rating scale for depression
    Hamilton M [1960]
  • The pathophysiology of hypoactive sexual desire disorder in women
    Clayton AH [2010]
  • The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study
    Marcus RN [2008]
  • Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians
  • Statistical Power Analysis For the Behavioral Sciences
  • Sex differences in rates of depression: cross-national perspectives
    Weissman MM [1993]
  • Sensitivity to the depressogenic effect of stress and HPA-axis reactivity in adolescence: a review of gender differences
  • Quantitative rating of depressive states
    Bech P [1975]
  • Poor response to antidepressant medication of patients with depression accompanied by somatic symptomatology in the STAR*D Study
  • Novel drugs and therapeutic targets for severe mood disorders
    Mathew SJ [2008]
  • Improving the assessment of severity of depressive states: a reduction of the Hamilton Depression Scale
    Maier W [1985]
  • Gender differences in major depressive disorder: results from the Netherlands study of depression and anxiety
    Schuch JJ [2014]
  • Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
    Bijl RV [2002]
  • Exactly what does the Hamilton depression rating scale measure
  • Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies
    Nelson JC [2010]
  • Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series
    Nagoshi Y [2014]
  • Dopamine D(3) receptor as a new pharmacological target for the treatment of depression
    Leggio GM [2013]
  • Diagnosis and definition of treatment-resistant depression
    Fava M [2003]
  • Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study
    Cheon EJ [2017]
  • Comparing outcomes of adjunctive treatment in depression: aripiprazole versus bupropion
    Nasr S [2014]
  • Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism
    Naber D [2004]
  • Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability
    DeLeon A [2004]
  • Aripiprazole augmentation in major depressive disorder:a double-blind, placebo-controlled study in patients with inadequate response to antidepressants
    Berman RM [2009]
  • An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies
    Evans KR [2004]
  • A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor
    Stahl SM [2004]